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Abstract 
Background: Genome mining facilitated by heterologous systems is an emerging approach to access the chemical 
diversity encoded in basidiomycete genomes. In this study, three sesquiterpene synthase genes, GME3634, GME3638, 
and GME9210, which were highly expressed in the sclerotium of the medicinal mushroom Lignosus rhinocerotis, were 
cloned and heterologously expressed in a yeast system.
Results: Metabolite profile analysis of the yeast culture extracts by GC–MS showed the production of several ses‑
quiterpene alcohols  (C15H26O), including cadinols and germacrene D‑4‑ol as major products. Other detected ses‑
quiterpenes include selina‑6‑en‑4‑ol, β‑elemene, β‑cubebene, and cedrene. Two purified major compounds namely 
(+)‑torreyol and α‑cadinol synthesised by GME3638 and GME3634 respectively, are stereoisomers and their chemical 
structures were confirmed by 1H and 13C NMR. Phylogenetic analysis revealed that GME3638 and GME3634 are a pair 
of orthologues, and are grouped together with terpene synthases that synthesise cadinenes and related sesquiter‑
penes. (+)‑Torreyol and α‑cadinol were tested against a panel of human cancer cell lines and the latter was found to 
exhibit selective potent cytotoxicity in breast adenocarcinoma cells (MCF7) with  IC50 value of 3.5 ± 0.58 μg/ml while 
α‑cadinol is less active  (IC50 = 18.0 ± 3.27 μg/ml).
Conclusions: This demonstrates that yeast‑based genome mining, guided by transcriptomics, is a promising 
approach for uncovering bioactive compounds from medicinal mushrooms.
Keywords: Lignosus rhinocerotis, Tiger milk mushroom, Sesquiterpene synthase, Sesquiterpenoid, (+)‑Torreyol, 
α‑Cadinol, Heterologous expression, Saccharomyces cerevisiae
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Background
Basidiomycete mushrooms are important sources of bio-
active secondary metabolites including terpenoids, alka-
loids, and polyketides [1]. Exploration of the medicinal 
and pharmacological potential of these underexplored 
mushroom species could be scientifically and biotech-
nologically rewarding. Lignosus rhinocerotis (Cooke) 
Ryvarden (orthographic variant is L. rhinocerus; common 
name: tiger milk mushroom) belongs to the order Poly-
porales (Polyporaceae family). It has been found in tropi-
cal regions in China, East Africa, Sri Lanka, Thailand, 
Philippines, Indonesia, Papua New Guinea, Australia, 
Vanuatu, and Malaysia [2–4]. Lau et al. [5] has compiled 
the ethnomycological uses of the sclerotia of the mush-
room by different communities including the Malay, Chi-
nese, and several sub-tribes of indigenous communities 
in Peninsular Malaysia including the Temuans and Semai 
aborigines to treat coughs, asthma, tuberculosis, and can-
cer; where several preparation methods of the fungus for 
medicinal purposes have been documented. Both aque-
ous (e.g., decoction) and non-aqueous preparations (e.g., 
tincture) have been reported, which may indicate the 
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presence of hydrophilic and lipophilic active substances, 
respectively [5].
The genome and transcriptome studies of L. rhinoc-
erotis have provided insights into the biology of this 
medicinal mushroom and opened up new opportuni-
ties for exploration via genomic approaches [6–9]. Tran-
scriptomics analysis revealed genes encoding several 
small secreted cysteine-rich proteins (cerato-platanins 
and hydrophobins) and lectins were among the highest 
expressed genes in the sclerotium of L. rhinocerotis and 
may have important implications for various bioactivities 
relevant to human diseases [7]. On the other hand, the L. 
rhinocerotis genome harbours genes encoding a number 
of secondary metabolite biosynthetic enzymes, including 
12 sesquiterpene synthases (STSs), one non-ribosomal 
peptide synthetase (NRPS), and a polyketide synthase 
(PKS) [6]. These enzymes are crucial for the biosynthesis 
of sesquiterpenes, non-ribosomal peptides, and polyke-
tides, respectively. Among them, six secondary metabolite 
gene clusters harbouring genes encoding four STS genes 
and one each of NRPS and PKS were also found to express 
at notable levels in the L. rhinocerotis sclerotium [7].
Genome mining has emerged as a potential avenue to 
access the chemical diversity encoded in basidiomycete 
fungal genomes [10]. The large number of STS genes in 
the genome highlights the potential of L. rhinocerotis in 
producing diverse sesquiterpenoids. Many sesquiterpe-
noids have potent antibiotic and cytotoxic activities due 
to their high chemical reactivity [11]. Some renowned 
fungal sesquiterpenoids include the anticancer active 
illudins from Omphalotus olearius [12], the cytotoxic PR 
toxin (from Penicillium roqueforti) with robust antimi-
crobial activity [13], and the platelet aggregation inhibitor 
radulone A from Radulomyces confluens [11]. The basidi-
omycete STSs have been shown to be readily expressed in 
well-established laboratory hosts, such as Escherichia coli 
and Saccharomyces cerevisiae [12, 14]. This makes heter-
ologous expression an attractive approach for accessing 
the basidiomycete terpenoid chemistry, as many basidi-
omycete fungi are relatively slow growing in the labora-
tory environment.
We have only begun to appreciate the diversity of STSs 
in basidiomycetes [10]. Nonetheless, sesquiterpene bio-
synthesis of Polyporales which consist of several medici-
nal mushrooms including Ganoderma lucidum [15], 
Antrodia cinnamomea [16], Trametes versicolor [17] and 
L. rhinocerotis (this study), remained largely unexplored. 
Given that S. cerevisiae has proven to be extremely use-
ful for genome mining and characterisation of fungal 
secondary metabolite pathways [18] as well as for com-
mercial production of terpenoids [19], we have chosen 
to use the yeast as an expression host for L. rhinocerotis 
STSs in this study. Guided by previous transcriptomic 
data, we cloned several sclerotium-expressed L. rhinoc-
erotis STS genes for heterologous expression in a S. cer-
evisiae yeast system. The putative products from these 
STSs were identified by gas chromatography-mass spec-
trometry (GC–MS). Two major sesquiterpene alcohol 
products were isolated and further characterised struc-
turally. The potential cytotoxic activities of the two com-
pounds against a panel of human cancer cell lines were 
also examined.
Methods
Mushroom material and DNA extraction
L. rhinocerotis TM02 strain (TM02) was obtained from 
LiGNO™ Biotech (Selangor, Malaysia). The fungus was 
authenticated by its nuclear ribosomal internal tran-
scribed spacer (ITS) region using FTM and ITS4 primers 
[20]. A voucher specimen was deposited at Royal Botanic 
Gardens, Kew (London, UK) with the accession number 
K(M) 177812. DNA was extracted using a modified hexa-
decyl trimethyl-ammonium bromide method [21].
Gene cloning and plasmid construction
The coding sequences of the three STS genes, GME3634, 
GME3638, and GME9210, in the sequenced TM02 
genome, have been revised based on the recent RNA 
sequencing data [6, 7]. The revised coding sequences 
are presented in Additional file  1: Table S1 and depos-
ited in GenBank for public access under accession num-
bers KX281943, KX281944, and KX281945, respectively. 
Individual exons of the STS genes were amplified by PCR 
with 35–40 bp overhangs that overlap with neighbouring 
exons or plasmid backbone and stitched together to form 
the respective ‘intronless’ cDNA genes by yeast-mediated 
in  vivo DNA recombination. The oligonucleotide prim-
ers used for constructing the genes are listed in Addi-
tional file  1: Table S2. PCR reactions were performed 
using  Q5® High-Fidelity DNA Polymerase (New England 
Biolabs) according to the manufacturer’s protocol at an 
annealing temperature of 66  °C. In  vivo yeast recombi-
nation cloning was carried out using a Frozen-EZ Yeast 
Transformation II Kit™ (Zymo Research) where compe-
tent S. cerevisiae BJ5464 [22] was transformed with the 
DNA fragments (PCR products) of the respective genes 
and linearized plasmid backbone derived from YEplac-
ADH2p [23, 24]. Yeast transformants grown on synthetic 
dropout agar plate lacking uracil were screened by PCR. 
Plasmid DNA was isolated from positive transformants 
using a Zymoprep™ Yeast Plasmid Miniprep II Kit (Zymo 
Research) and used to transform NEB 5-alpha Electro-
competent E. coli (New England Biolabs) by electropora-
tion. Plasmid DNA was isolated from the positive clones 
grown on LB-ampicillin using the alkaline lysis method 
and further verified by DNA sequencing.
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Heterologous expression in yeast system
Saccharomyces cerevisiae BJ5464 was transformed 
with the three verified STSs (GME3634, GME3638, or 
GME9210) expression constructs. For small scale analy-
sis, individual single yeast colonies were grown in 3  ml 
of yeast synthetic dropout medium lacking uracil as 
a starter culture for 72 h at 28  °C under shaking condi-
tions (200 rpm). A total of 100 ml YPD (or yeast extract-
peptone-dextrose) broth was inoculated with 100  µl 
of the starter culture and incubated for 90  h at 28  °C 
under shaking conditions (200  rpm). Cells were pel-
leted at 5000×g for 15 min and extracted with an equal 
volume of acetone at room temperature (RT). Samples 
were analysed by GC–MS as described below. For large 
scale production of the sesquiterpenes, the S. cerevisiae 
BJ5464 harbouring GME3634, GME3638, or GME9210, 
were grown in 7 ml of synthetic dropout medium lacking 
uracil as a starter culture for 72 h at 28 °C under shaking 
conditions (200 rpm). Six millilitres of the starter culture 
were inoculated into 6 l of YPD broth and incubated 90 h 
at 28 °C under shaking conditions (200 rpm). Cells were 
pelleted as before and extracted with acetone.
Isolation, purification, and identification of sesquiterpenes
The extraction of sesquiterpenes from yeast was per-
formed as described previously [25]. The yeast cell pellet 
was extracted with an equal volume of acetone twice at 
room temperature and concentrated by rotary evapora-
tor to remove the acetone from the extract. The aque-
ous portion was partitioned twice with dichloromethane 
(DCM). The DCM fraction was then subjected to silica 
gel  (SiO2) flash chromatography separation with a sim-
ple linear 100% hexane to 100% ethyl acetate gradient 
using a  Reveleris® X2 Flash Chromatography System 
(GRACE, Columbia, MD, USA). Fractions were ana-
lysed by GC–MS on a Shimadzu GC–MS QP2010 to 
confirm the presence of the sesquiterpene. Samples were 
injected into the injector port at 250 °C in splitless mode 
and eluted with helium into a Rtx-5MS column (30.0 m 
length × 0.25 mm inner diameter × 0.25 µm film thick-
ness) (Restek, Bellefonte, PA, USA). The following GC 
oven temperature program was applied: 35 °C hold for a 
minute, 30 °C/min ramp to 70 °C and hold for 2 min, fol-
lowed by a 15  °C/min ramp to 159  °C, then a 6  °C/min 
ramp to 217  °C and finally a 16  °C/min ramp to 325  °C 
and hold for 3 min (total program time: 29.52 min). The 
software used for the acquisition and data analysis was 
GCMSsolution software (Shimadzu, Kyoto, Japan). Com-
pounds were putatively identified by comparing the mass 
spectra (45–320 m/z range) to the NIST 05 library (NIST, 
Gaithersburg, MD, USA). 1H, 13C, and 2D NMR spectra 
of (+)-torreyol and α-cadinol were obtained in deuter-
ated chloroform  (CDCl3) using either a Bruker Avance 
IIIHD 500 or 600  MHz spectrometer. The optical rota-
tions of (+)-torreyol and α-cadinol were determined 
using an Autopol 1 polarimeter (Rudolph Research Ana-
lytical, Hackettstown, NJ, USA).
Phylogenetic tree construction
Close protein sequence homologs of GME3634, 
GME3638, and GME9210 obtained from NCBI using 
BLASTP (E value  <1e-114, Identity  >47%), along with 
several previously reported and characterised STSs from 
Coprinus cinereus (Cop1, Cop2, Cop3, Cop4, Cop5, 
Cop6) [14] and O. olearius (Omp1, Omp2, Omp3, Omp4, 
Omp5a, Omp5b, Omp6, Omp7, Omp8. Omp9, Omp10) 
[12], were used for phylogenetic analysis. In addition, 
protein sequences of two STSs from Arabidopsis thali-
ana, At5g44630 and At5g23960 [26], were included to 
root the phylogenetic tree. The protein sequences were 
aligned with the sequence alignment integrated tool 
(ClustalW) from MEGA6 [27] and the poorly align-
able regions were removed by the GBlocks server using a 
less stringent selection [28]. The ProtTest 2.4 server was 
used to select the best fit empirical substitution model 
of protein evolution based on the Bayesian information 
criterion [29]. A bootstrap test of phylogeny to construct 
maximum-likelihood tree was conducted using MEGA6 
with 1000 replicates based on the Le_Gascuel_2008 (LG) 
model [30]. From this, a single consensus tree with ≥ 70% 
majority-rule was built.
Cell viability assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) colorimetric assay was used to 
assess cell viability where the yellow tetrazolium dye is 
reduced to the insoluble, purple crystalline formazan in 
metabolically active viable cells by NAD(P)H-depend-
ent cellular oxidoreductases. Mammary gland epithe-
lium (184B5, CRL-8799™), epithelial mammary gland 
adenocarcinoma (MCF7, HTB-22™), epithelial lung 
carcinoma (A549, CCL-185™), and epithelial prostate 
adenocarcinoma (PC-3, CRL-1435™) cells were pur-
chased from  ATCC® (Manassas, VA). MCF7, A549, and 
PC-3 cell lines were maintained in Roswell Park Memo-
rial Institute (RPMI)-1640 while 184B5 cell line was 
cultured in Mammary Epithelial Cell Growth Medium 
(MEGM) bullet kit. Monolayer cells grown in 96-well 
plate were treated with the isolated sesquiterpenes dis-
solved in ≤0.4% dimethyl sulfoxide (DMSO) at different 
concentrations (0.625–40  µg/ml). The MTT solution of 
5 mg/ml in phosphate-buffered saline solution (PBS) was 
added 72  h post-treatment and the plate was incubated 
at 37 °C for an additional 4 h until formazan developed. 
The MTT-containing spent medium was aspirated out 
and an equal amount of DMSO was added to dissolve the 
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formazan and absorption was measured at 570 nm. The 
 IC50 value was determined from the cell viability percent-
ages against the concentrations curve. The untreated and 
vehicle-treated cells served as control groups.
Results
Heterologous expression of L. rhinocerotis STS genes 
resulted in the production of diverse sesquiterpenes 
in yeast
Genome sequencing revealed that L. rhinocerotis is rich 
in STS genes (12 in total) [6] while transcriptome study 
showed that seven out of the 12 terpene synthase genes 
are actively expressed in the sclerotium, which is the 
part of the mushroom used in traditional medicine [7]. 
Based on this reported data from previous literature, 
we attempted to express the three terpene synthase 
genes GME3634, GME3638, and GME9210 that were 
most highly expressed in the sclerotium. GME3634 
and GME3638 clustered together on scaffold 22 which 
also includes a gene encoding an aldo/keto reductase 
(GME3639) while GME9210 forms another terpene gene 
cluster together with a NAD-P-binding protein and an 
ABC transporter located at scaffold 346 of the L. rhinoc-
erotis genome assembly [6, 7]. Comparison of the GC–
MS profiles of the yeast cultures expressing GME3634, 
GME3638, or GME9210 against the empty vector yeast 
control revealed the putative sesquiterpene alcohols 
 (C15H26O) germacrene D-4-ol and cadinols as the major 
products. Other minor compounds were putatively 
identified as selina-6-en-4-ol, β-elemene, β-cubebene, 
and cedrene based on strong matches with spectra in 
the NIST database (Table  1). Among the synthases, 
GME3638 produced the highest number of sesquiter-
penes, 19 in total and six of them were sesquiterpene 
alcohols, followed by GME3634 which produced eight 
sesquiterpenes including five alcohols, and GME9210 
with two sesquiterpenes, one of them an alcohol. No ses-
quiterpenes were detected in the empty vector control. 
GC–MS metabolite profiles of the culture extracts are 
shown in Fig. 1.
A single peak with a retention time (RT) of 12.1  min 
identified as torreyol (syn. δ-cadinol) with significant 
abundance was consistently present in the profile of 
GME3638-expressing yeast. GME3634 produced two 
notable peaks with moderate abundances at RT of 11.37 
and 12.18  min identified as germacrene D-4-ol and 
α-cadinol respectively. In contrast, GME9210 only pro-
duced sesquiterpenes at comparatively low abundances, 
including 1,3,4,5,6,7-hexahydro-2,5,5-trimethyl-2H-2,4a-
ethanonaphthalene (Fig.  1). Therefore, we focused on 
isolating and identifying the major compounds from 
GME3638 and GME3634.
GME3638 and GME3634 expression in yeast produced 
(+)‑torreyol and α‑cadinol
Extraction from six litre cultures of GME3638- and 
GME6364-expressing yeast enabled the purification of 
5.1 ±  0.50 and 1.0 ±  0.25 mg of the two putative com-
pounds namely torreyol (RT =  12.1 min) and α-cadinol 
(RT =  12.18  min) (Fig.  1). Mass spectra of the isolated 
compounds compared to those compounds in the data-
bases are shown in Additional file 1: Figure S1. Both com-
pounds presented a similarity index of 95% in the NIST 
library, which is highly significant. NMR experiments 
were performed to confirm the identities of the com-
pounds with the compound produced by GME3638 cor-
responding to (+)-torreyol, while GME3634 produced 
α-cadinol (Additional file 1: Table S3; Fig. 2).
Polarimetric analysis showed that the optical rotation 
of both compounds corresponded to those reported 
previously for (+)-torreyol and α-cadinol, respectively 
[31–33]. Taken together, we demonstrated that the ses-
quiterpene biosynthetic genes GME3638 and GME3634 
are involved in the biosynthesis of (+)-torreyol and 
α-cadinol, respectively (Table 1; Fig. 1). Both compounds 
have been previously reported and identified as ses-
quiterpene alcohols isolated from plants but have been 
reported in only limited cases from fungi [31, 34–36].
Phylogeny of STSs GME3634 and GME3638
BLAST searches across fungal genomes showed that 
only a few of the STSs from basidiomycetes have been 
functionally characterised with the majority from recent 
genome-wide studies on O. olearius and C. cinereus [12, 
14]. Phylogenetic analysis of GME3634, GME3638, and 
GME9210 against 50 other STS sequences (both putative 
and characterised) resulted in a phylogenetic tree reveal-
ing three distinct Basidiomycete sesquiterpene clades, 
termed Clades I, II, and III based on previous analysis [12, 
14], with the outgroup consisting of the florally expressed 
terpene synthase genes At5g23960 and At5g44630 of 
A. thaliana [26] (Fig. 3). Both GME3634 and GME3638 
(sharing 57.2% protein identity) were grouped into Clade 
I and were further segregated into subclade Ia and Ib, 
respectively. Ib consists of STSs from diverse basidiomy-
cete fungi but Ia exclusively consists of uncharacterised 
STSs of the Polyporaceae family, including those from T. 
versicolor, T. cinnabarina, Dichomitus squalens, Postia 
placenta, and Fomitopsis pinicola, suggesting that STSs 
in subclade 1a are conserved taxonomically. Interest-
ingly, the occurrence of GME3634 and GME3638 gene 
homologs as a pair in a gene cluster were also observed 
in T. versicolor (XP008039662.1/XP0080339659.1), T. cin-
nabarina (CDO74941.1/CDO74937.1), and D. squalens 
(XP007362515.1/XP007362521.1).
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Table 1 Heterologous production of  sesquiterpenes in  S. cerevisiae BJ5464 expressing GME3634, GME3638, 
and GME9210
RT (min) SI (%) Peak area Formula Name Structure
GME3634
 10.315 65 400,382 (C15H24) Unknown sesquiterpene
 10.790 74 282,208 (C15H24) Unknown sesquiterpene
 10.855 68 187,589 (C15H24) Unknown sesquiterpene
 11.370 91 3,367,644 C15H26O Germacrene D‑4‑ol
 11.820 75 66,158 (C15H26O) Unknown sesquiterpene
 12.035 89 525,206 C15H26O τ‑Muurolol
 12.080 74 84,666 (C15H26O) Unknown sesquiterpene
 12.175 95 4,408,840 C15H26O α‑Cadinol
GME3638
 9.510 92 501,063 C15H24 α‑Copaene
 9.590 88 506,236 C15H24 β‑Elemene
 9.655 94 4,396,543 C15H24 β‑Elemene
 9.915 76 197,793 (C15H24) Unknown sesquiterpene
 10.200 86 764,201 C15H24 Isoledene
 10.315 55 707,826 (C15H24) Unknown sesquiterpene
 10.430 89 1,820,157 C15H24 Germacrene D
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Table 1 continued
RT (min) SI (%) Peak area Formula Name Structure
 10.480 94 1,041,092 C15H24 Germacrene D
 10.590 87 1,068,119 C15H24 β‑Cubebene
 10.645 95 2,408,088 C15H24 α‑Muurolene
 10.855 83 1,246,428 C15H24 δ‑Cadinene
 10.940 68 603,336 (C15H24) Unknown sesquiterpene
 11.455 69 254,072 (C15H24) Unknown sesquiterpene
 10.795 82 3,768,107 C15H26O Selina‑6‑en‑4‑ol
 11.375 94 8,944,970 C15H26O Germacrene D‑4‑ol
 11.510 75 963,361 (C15H26O) Unknown sesquiterpene
 11.830 86 805,039 C15H26O Germacrene D‑4‑ol
 12.100 95 41,559,921 C15H26O Torreyol
 12.180 93 1,713,657 C15H26O α‑Cadinol
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Table 1 continued
RT (min) SI (%) Peak area Formula Name Structure
GME9210
 9.535 88 734,814 C15H24 1,3,4,5,6,7‑Hexahydro‑2,5,5‑trimethyl‑2H‑2,4a‑ethanonaphthalene
 11.375 74 512,708 (C15H26O) Unknown sesquiterpene
Possible candidate with the highest SI is shown for compound identification. Sesquiterpenes with SI lower than 80 but with predicted molecular formula typical of 
sesquiterpenes are listed as unknown sesquiterpene
RT retention time, SI similarity index
Fig. 1 Heterologous production of sesquiterpenes in S. cerevisiae BJ5464 expressing GME3634, GME3638, and GME9210. GC–MS profile of the 
culture extracts in comparison to the profile of the empty vector (control)
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STSs from O. olearius and C. cinereus have been char-
acterised in previous genome-wide studies using E. coli 
and/or S. cerevisiae as heterologous expression systems 
[12, 14]. The STSs from C. cinereus (Cop1—3) and O. 
olearius (Omp1—3) that utilize a 1,10-cyclization of 
(2E,6E)-farnesyl pyrophosphate (FPP) to produce ses-
quiterpenes derived from an (E,E)-germacradienyl cat-
ion fall into Clade I, but they formed separate subclades 
from GME3634 and GME3638. Cop1 and Cop2 synthe-
sise germacrene A as the major product while Cop3 and 
Omp1 are α-muurolene synthases [12, 14]. In addition to 
α-muurolene, Omp3 also synthesises β-elemene, selina-
4,7-diene, and δ-cadinene. Omp2 was reported to be 
not functional by Wawrzyn et al. [12]. In contrast to the 
Clade I STSs from C. cinereus and O. olearius, GME3634 
and GME3638 produce the related sesquiterpene alco-
hols from 1,10-cyclization of (2E,6E)-FPP as major prod-
ucts, including germacrene-4-ol and cadinols (Fig. 1).
GME9210 was grouped into Clade II, which consists of 
Omp6 and Omp7 which is involved in the synthesis of the 
anticancer illudin precursor, Δ-6 protoilludene. Further 
pairwise sequence identity and similarity calculations 
from the multiple sequence alignment of GME9210 to 
Omp6 and Omp7 indicated that GME9210 is 58 and 62% 
identical and 64 and 68% similar to Omp6 and Omp7, 
respectively. Majority of STSs in this clade were postu-
lated to share a common 1,11-cyclization of (2E,6E)-FPP 
mechanism, producing the trans-humulyl cation [12]. We 
were unable to obtain the sesquiterpene product from 
GME9210 in sufficient amount for NMR analysis due to 
the low yield in S. cerevisiae, though it was tentatively 
assigned with the putative structure  1,3,4,5,6,7-hex-
ahydro-2,5,5-trimethyl-2H-2,4a-ethanonaphthalene 
(Table  1) based on GC–MS analysis. No biosynthetic 
pathway has been proposed for 1,3,4,5,6,7-hexahy-
dro-2,5,5-trimethyl-2H-2,4a-ethanonaphthalene. It is 
yet unknown if the sesquiterpene could be formed via 
1,11-cyclization or 1,6-cylization of FPP.
(+)‑Torreyol and α‑cadinol exhibited selective cytotoxicity 
against MCF7 cells
(+)-Torreyol and α-cadinol have been found to be a part 
of major constituents of essential oils of different plant 
species displaying cytotoxic effect against human oral, 
liver, lung and colon melanoma, and leukemic cancer 
cells [37, 38]. However, reports on the anticancer activ-
ity of these compounds in pure form are still limited. 
Thus, we examined the role of the isolated (+)-tor-
reyol and α-cadinol as potential anticancer agent(s). 
We tested the anti-proliferative and cytotoxic activi-
ties of both compounds against MCF7 using an MTT 
assay. Both compounds showed marked toxicity against 
MCF7 cells where (+)-torreyol was approximately five 
times more potent than α-cadinol (Fig.  4). According 
to the criteria established by the USA National Cancer 
Institute (NCI), pure compounds with  IC50 values less 
than 4 μg/ml following an incubation period of 48–72 h 
are considered to be cytotoxic agents [39]. Therefore, 
(+)-torreyol can be considered cytotoxic against MCF7 
cells with  IC50 of 3.5  ±  0.58  μg/ml. We further tested 
the cytotoxic effect of (+)-torreyol against A549, PC-3 
and the non-tumorigenic 184B5 mammary gland cell 
line corresponding to MCF7. (+)-Torreyol showed 
less cytotoxicity to A549  (IC50 = 6.5 ± 3.28 µg/ml) and 
PC-3 cells  (IC50  =  12.5  ±  1.50  µg/ml) while its cyto-
toxicity was at least sixfold lower towards 184B5 cells 
Fig. 2 Structures of (+)‑torreyol (1) and α‑cadinol (2)
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Fig. 3 Phylogeny and distribution of GME3634, GME3638, and GME9210 from L. rhinocerotis TM02 with selected fungal sesquiterpene synthase 
homologs. Rooted maximum‑likelihood tree with the highest log likelihood (−14290.4851) is shown. The tree is drawn to scale, with branch lengths 
measured in the number of substitutions per site. Percentage of trees in which the associated taxa clustered together is shown next to the branches 
labelled with gene names or gene accession numbers with abbreviated strain names
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 (IC50 = 22.7 ± 1.15 µg/ml) (Fig. 4). The selective cytotox-
icity of (+)-torreyol against MCF7 makes it a good candi-
date for potential anticancer agent development.
Discussion
Saccharomyces cerevisiae yeast has emerged as a power-
ful host cell for genome mining, biosynthetic studies, and 
production of fungal secondary metabolites, as it has many 
advantages [18, 19]. For expression of isoprenoid path-
ways, yeast readily provides the FPP substrate for STSs and 
has the added advantage of the ability to co-express func-
tional cytochrome P450 monooxygenases that are often 
found encoded in terpene synthase gene clusters with 
compatible fungal cytochrome P450 reductase [40–43]. 
Successful expression of basidiomycete (Agaricales) STSs 
have been previously demonstrated in yeast [14]. However, 
this is the first report of the characterisation of STSs from 
the Polyporaceae family of mushrooms, which include sev-
eral well-known medicinal mushrooms including G. luci-
dum and Antrodia camphorata.
Previous studies reported the expression of several 
sesquiterpene biosynthetic gene clusters in the genome 
and transcriptome of L. rhinocerotis [6, 7] but identifica-
tion of their metabolic products remains elusive. In this 
study, we heterologously expressed three STSs namely 
GME3634, GME3638, and GME9210 in order to func-
tionally characterise their metabolic products. GME9210 
produced several sesquiterpenes at low abundances 
including 1,3,4,5,6,7-hexahydro-2,5,5-trimethyl-2H-2,4a-
ethanonaphthalene  (C15H24) while GME3638 and 
GME3634 encoded STSs that produce (+)-torreyol and 
α-cadinol, respectively, as major products. Both com-
pounds are sesquiterpene alcohols and have been previ-
ously characterised but for the first time, the polypore L. 
rhinocerotis (Polyporaceae) has been shown to encode the 
pathways for biosynthesis of these sesquiterpene alcohols.
In this study, using the sequence and function data of 
the characterised STSs from C. cinereus (Cop1—6) and 
O. olearius (Omp1—10) as guide [12, 14], we extended 
the analysis by including the newly identified STSs from 
L. rhinocerotis as well as putative STS sequences from 
various Polyporaceae basidiomycetes to provide insights 
into the diversity and biochemical functions of STSs in L. 
rhinocerotis. It is interesting to note that GME3634 and 
GME3638 gene homologs exist as a pair in a gene cluster 
and are responsible for production of isomeric sesquiter-
penes, (+)-torreyol and α-cadinol, with different stereo-
chemistry. Similar paired GME3634/GME3638 homologs 
were also found in T. versicolor, T. cinnabarina, and D. 
squalens as clustered genes, suggesting that they are con-
served in multiple Polyporaceae mushrooms. Their high 
homology and conserved synteny suggest that these STS 
homologs may be involved in the biosynthesis of (+)-tor-
reyol and α-cadinol and/or related sesquiterpenes, which 
may serve common biological functions.
The occurrence of the major sesquiterpenic alco-
hols in the cultures of yeast harbouring GME3634 and 
GME3638 presents an interesting question whether these 
alcohols are the direct product of the enzymes. Wawrzyn 
et  al. [12] suggested that (+)-torreyol from the Agari-
cales mushroom O. olearius is derived from α-muurolene 
synthesised by the α-muurolene synthase Omp1. A sin-
gle P450 oxygenase gene collocated with omp1 in the 
biosynthetic cluster was proposed to be responsible for 
converting α-muurolene to (+)-torreyol [12]. GME3638, 
which synthesises (+)-torreyol, shares 43% identity to 
Omp1. However, we have not detected the major pro-
duction of α-muurolene in the culture of yeast express-
ing GME3638, but just a minor one. Instead, we have 
detected germacrene D-4-ol as the second major product 
in addition to (+)-torreyol (Fig. 1). The same is true for 
GME3634, in which the gene clustered with GME3638 
and produced the stereoisomer α-cadinol with germac-
rene D-4-ol as the second major product in yeast culture. 
Although we cannot completely ruled out that an endog-
enous yeast enzyme (e.g. a hydroxylase) could affect the 
end product of the two STSs observed in the yeast cul-
tures, we proposed that GME3638 and GME3634 could 
produce (+)-torreyol and α-cadinol as the direct product 
resulting from hydrolysis of the muurolenyl or cadinenyl 
cation, respectively (Additional file 1: Figure S2). Further 
in  vitro characterisation of the enzymes is required to 
elucidate the biosynthetic mechanism of GME3634 and 
GME3638.
Phylogenetic analysis indicates that GME3638 and 
GME3634 belong to the same clade (Clade I) together 
with the α-muurolene synthase Omp1, the germacrene A 
synthases Cop1 and Cop2 [14], as well as several putative 
uncharacterised STSs from closely related taxa (Fig.  3). 
Fig. 4 Cytotoxic activity of α‑cadinol and (+)‑torreyol in MCF7 and 
184B5 cells. Effect of compounds on the viability of cells was exam‑
ined by measuring relative cell viability via MTT assay (values are as 
mean ± SD, n = 3)
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Of note is that the germacranyl cation is the key inter-
mediate of many cadinene group compounds (which 
includes muurolenes) [44, 45], while germacrene D and 
germacrene D-4-ol are constantly detected as a side 
product in the yeast strains expressing GME3634 and 
GME3638 (Table 1). This is congruent with the germac-
ranyl cation being an essential biosynthetic intermediate 
of muurolenes and cadinenes (Additional file  1: Figure 
S2). In line with the previous study [12], it appears that 
although the STS phylogenetic analysis was unable to 
provide an accurate prediction of the structures of the 
sesquiterpene products at this stage due to the lack of 
characterised STSs from basidiomycetes, the grouping of 
the STSs into major clades gave a good indication of the 
initial cyclization step.
α-Cadinol is a common major constituent of various 
bioactive essential oils and plant extracts, such as those 
obtained from Lindera nacusua, Zingiber nimmonii, and 
Beilschmiedia madang [46–48]. A structure–activity rela-
tionship study of cadinane skeletal sesquiterpenes from 
Taiwania heartwood (Taiwania cryptomerioides) indi-
cated that the presence of an equatorial hydroxyl (–OH) 
group at C-10 with a trans-fused configuration at the 
ring junction has a positive influence on their antifungal 
activities [36], such is the case of α-cadinol and therefore 
some antifungal activity may be expected. On the other 
hand, with a cis-fused rings feature, the torreyol belongs 
to the muurolene-type of compounds in contrast to the 
cadinene and their related cadinols which have a trans-
fused ring structure [34]. Torreyol can be (+) or (−) 
depending if it is dextrorotatory or levorotatory; these 
isomers have been described by the names δ-cadinol, 
sesquigoyol, pilgerol, cedrelanol, and albicaulol [34]. The 
name torreyol is widely used due to its priority in usage. 
(+)-Torreyol was first isolated as white crystalline nee-
dles from the leaves of Torreya nucifera [49] and later in 
a few basidiomycetes including Clitocybe illudens (syno-
nym O. olearius) grown on agar medium, Lentinus lepi-
deus, and Xylobolus frustulatus [31, 50].
Investigations into elucidating the bioactive com-
pounds in order to discover the scientific basis of the 
traditional uses of L. rhinocerotis recorded by ethnomy-
cological surveys are currently emerging. In particular, its 
anticancer activities have been well explored by several 
research groups [9, 51, 52]. A partially purified fraction 
made up of two putative cytotoxic subtilisin-like fungal 
serine proteases has been recently reported to exhibit 
apoptosis-inducing activity in MCF7 cells [9] and more 
recently, Pushparajah et al. [52] synthesised a functional 
recombinant lectin-like fungal immunomodulatory pro-
tein using cDNA of L. rhinocerotis, which exhibit cyto-
toxicity against cancer cell lines. While the reported 
bioactive compounds are of high molecular weight 
protein molecules, here, we characterised three STSs 
from L. rhinocerotis using yeast heterologous system, 
which led to the discovery of (+)-torreyol that exhibited 
potent cytotoxicity against MCF7 and α-cadinol that is 
less active. To our knowledge, this is the first report on 
the bioactivity of (+)-torreyol and α-cadinol in pure form 
as these compounds are usually assayed in mixture. In 
view of the promising bioactivity of (+)-torreyol, future 
directions may include in-depth studies on its pharma-
cological activities in vivo and the underlying molecular 
mechanisms.
Conclusions
Two cytotoxic sesquiterpene alcohols, (+)-torreyol and 
α-cadinol, were isolated and purified from the yeast sys-
tem expressing the L. rhinocerotis STSs GME3638 and 
GME3634, respectively. (+)-Torreyol is selectively active 
against MCF7 cells with  IC50 value of 3.5 ± 0.58 μg/ml. 
This study provided insights into the biocatalytic activi-
ties of basidiomycete STSs and provides a platform for 
further genome mining of bioactive secondary metabo-
lites from medicinal mushrooms of the Polyporaceae 
family. Future work will focus on characterisation of 
other STSs in L. rhinocerotis as well as on elucidating the 
in vivo anticancer activity and mechanism(s) of action of 
(+)-torreyol.
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